Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

OncLive TV: Mario Sznol, MD

<< Back to Our Featured Experts

Dr. Sznol on Factors to Consider When Combining VEGF TKIs/Immunotherapy in RCC

Dr. Sznol on Patient Selection for Combination Therapy in mRCC

Dr. Sznol on Unanswered Questions With Immunotherapy in RCC

Dr. Sznol Discusses Immunotherapy in Non-Clear Cell Renal Cancer

Dr. Sznol Discusses Immunotherapy Combinations in RCC

Dr. Sznol Discusses the Importance of Clinical Trials in RCC

Dr. Sznol Discusses Advancements in Immunotherapy for RCC

Dr. Sznol Discusses the Role of Surgery in Melanoma

Dr. Sznol on Immunotherapy in Patients With RCC

Dr. Sznol on Managing Toxicities in Treatment of Melanoma

Dr. Sznol on Combining Nivolumab and Ipilimumab for the Treatment of Advanced Melanoma

Oncology Specialists

ABCDEFGHIJKLMNOPQRSTUVWXYZ

Jose M. Pacheco, MD

Sukhmani Padda, MD

Eric Padron, MD

Olivia Pagani, MD

David B. Page, MD

Paul K. Paik, MD

Sumanta Kumar Pal, MD

Sangeetha Palakurthi, PhD

Jeanne M. Palmer, MD

Antonio Palumbo, MD

Shubham Pant, MD

Sophie Papa, PhD, MBBS, MRCP

Vassiliki Papadimitrakopoulou, MD

Vassiliki A. Papadimitrakopoulou, MD

Timothy S. Pardee, MD

Samir Parekh, MBBS

Samir Parekh, MD

Aparna Parikh, MD

Sameer Parikh, MD

Jae Park, MD

Jae H. Park, MD

Steven I. Park, MD

Chris Parker, MD

Andrew T. Parsa, MD, PhD

J. Kellogg Parsons, MD

Ann H. Partridge, MD, MPH

Electra D. Paskett, PhD

Harvey I. Pass, MD

Jyoti Patel, MD

Jyoti D. Patel, MD

Kashyap Patel, MD

Krish Patel, MD

Sandip P. Patel, MD

Mrinal Patnaik, MBBS

Akash Patnaik, MD, PhD

Debra Patt, MD

Briana Patterson, MD

Philip B. Paty, MD

Manju P. Paul, MD

Kelly Paulson, MD

Scott Paulson, MD

Anna C. Pavlick, DO

Luis Paz-Ares, MD, PhD

David Pearlstone, MD

Andrew L. Pecora, MD

Andrew Pecora, MD, FACP, CPE

Andrew L. Pecora, MD, FACP, CPE

Chad Pecot, MD

Marc Peeters, MD, PhD

Mark D. Pegram, MD

Nir Peled, MD PhD

Richard S. Pelman, MD

Naveen Pemmaraju, MD

Nathan Pennell, MD, PhD

Nathan A. Pennell, MD, PhD

Richard T. Penson, MD

David F. Penson, MD, MPH

Miguel-Angel Perales, MD

Edith A. Perez, MD

Roman Perez-Soler, MD

Alexander E. Perl, MD

Charles M. Perou, PhD

Emanuel F. Petricoin, III, PhD

Gyorgy Petrovics, PhD

Daniel P. Petrylak, MD

Alexandria Phan, MD

Tony Philip, MD

Philip A. Philip, MD, PhD, FRCP

Tycel J. Phillips, MD

Adrienne Phillips, MD, MPH

Martine Piccart, MD, PhD

Martine J. Piccart, MD, PhD

David Piccioni, MD, PhD

Vincent J. Picozzi, MD

Filippo Pietrantonio, MD

Christopher Pietras, MD

Christopher J. Pietras, MD

Yana Pikman, MD

Roberto Pili, MD

David J. Pinato, MD

David James Pinato, MD, MRCP, PhD

David J. Pinato, MD, PhD

Jenny Pincus, MD

A. Daniel Pinheiro, MD

Javier Pinilla-Ibarz, MD, PhD

Javier A. Pinilla-Ibarz, MD, PhD

Lauren Pinter-Brown, MD

Bilal Piperdi, MD

Robert Pirker, MD

Michael Pishvaian, MD, PhD

Cecile Pizot

David Planchard, MD, PhD

Elizabeth Plimack, MD

Michael A. Poch, MD

Seth M. Pollack, MD

Daniel A. Pollyea, MD

David Polsky, MD, PhD

Pierluigi Porcu, MD,

David C. Portnoy, MD

Edwin M. Posadas, MD

Edwin M. Posadas, MD, FACP

Marshall Posner, MD

Michael Postow, MD

Michael A. Postow, MD

Bhavana Pothuri, MD

Julio Pow-Sang, MD

Bayard L. Powell, MD

Charles Powell, MD

Matthew Powell, MD

Thomas Powles, MBBS, MRCP, MD

Thomas Powles, MD

Thomas Powles, MD, MBBS, MRCP

Aleix Prat, MD, PhD

John Primrose, MD, ChB, FRCP

Sandhya Pruthi, MD

Shannon Puhalla, MD

Michael Pulsipher, MD

Lajos Pustzai, MD, DPhil

Lajos Pusztai, MD

Lajos Pusztai, MD, DPhil

Igor Puzanov, MD

FDA Approvals in Myeloma and ITP, Applications Accepted in Myeloma and More

Trending Now

SOLO-1 Data Encourage Molecular Testing Immediately at Ovarian Cancer Diagnosis

FDA Approval Sought for Enfortumab Vedotin for Urothelial Cancer

Expert Highlights Need for Widespread Liquid Biopsy Use in Lung Cancer Treatment

Regorafenib/Nivolumab Combo to Be Explored in Phase III MSS CRC Trial

Publications

Covering Every Angle of Oncology Practice. Click a cover below, to view more.

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Oncology Nursing News
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc

OncLive Resources

Articles
Blogs
Conference Coverage
OncLive TV
Peer Exchange
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Forgot Password
Press Releases
Privacy Policy
Terms & Conditions